TP53 and neoplasm: Panobinostat activates alternative apoptotic pathways in HCC cells, also in TP53-deficient cells, and reduced angiogenesis in tumor xenografts [199], through modulation of extracellular signaling cascades via a CTGF-dependent pathway [200].